In PC12 cells, naringenin treatment 0.4 μM inhibited Aβ-induced AD apoptosis and neurotoxicity by PI3K/Akt/GSK-3β pathway activation and caspase-3 inhibition [158]. This evidence concerns the gene AKT1 and Alzheimer disease.